| Database ID | Agent | Target | Cancer Type | Detail |
| DB00421 | cetuximab | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00422 | cetuximab | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00423 | cetuximab | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00424 | cetuximab | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00425 | cetuximab | Epidermal growth factor receptor | esophageal cancer | view |
| DB00426 | cetuximab | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00427 | panitumumab | Epidermal growth factor receptor | esophageal cancer and esophagusgastroesophageal junction cancer | view |
| DB00428 | panitumumab | Epidermal growth factor receptor | esophageal cancer and esophagusgastroesophageal junction cancer | view |
| DB00429 | panitumumab | Epidermal growth factor receptor | esophageal cancer | view |
| DB00430 | panitumumab | Epidermal growth factor receptor | esophageal cancer and esophagusgastroesophageal junction cancer | view |
| DB00431 | nimotuzumab | Epidermal growth factor receptor | esophageal cancer | view |
| DB00432 | matuzumab | Epidermal growth factor receptor | gastric cancer and esophagusgastroesophageal junction cancer | view |
| DB00433 | matuzumab | Epidermal growth factor receptor | esophageal cancer and esophagusgastroesophageal junction cancer | view |
| DB00434 | matuzumab | Epidermal growth factor receptor | gastric cancer and esophagusgastroesophageal junction cancer | view |
| DB00435 | gefitinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |